Procyon Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Buy |
26,483
+3,536
| +15% | +$392K | 0.28% | 74 |
|
|
2025
Q1 | $2.57M | Sell |
22,947
-11,367
| -33% | -$1.27M | 0.16% | 141 |
|
|
2024
Q4 | $3.17M | Sell |
34,314
-1,930
| -5% | -$178K | 0.2% | 106 |
|
|
2024
Q3 | $3.04M | Buy |
36,244
+3,214
| +10% | +$269K | 0.21% | 109 |
|
|
2024
Q2 | $2.27M | Sell |
33,030
-1,202
| -4% | -$82.5K | 0.17% | 136 |
|
|
2024
Q1 | $2.51M | Buy |
34,232
+3,955
| +13% | +$290K | 0.19% | 124 |
|
|
2023
Q4 | $2.45M | Buy |
30,277
+1,263
| +4% | +$102K | 0.21% | 116 |
|
|
2023
Q3 | $2.17M | Buy |
29,014
+11,688
| +67% | +$876K | 0.22% | 112 |
|
|
2023
Q2 | $1.34M | Buy |
17,326
+7,246
| +72% | +$558K | 0.17% | 138 |
|
|
2023
Q1 | $836K | Sell |
10,080
-5,979
| -37% | -$496K | 0.14% | 148 |
|
|
2022
Q4 | $1.38M | Sell |
16,059
-1,983
| -11% | -$170K | 0.25% | 93 |
|
|
2022
Q3 | $1.11M | Buy |
18,042
+1,087
| +6% | +$67.1K | 0.27% | 84 |
|
|
2022
Q2 | $1.05M | Sell |
16,955
-1,000
| -6% | -$61.8K | 0.23% | 98 |
|
|
2022
Q1 | $1.07M | Sell |
17,955
-4,980
| -22% | -$296K | 0.22% | 97 |
|
|
2021
Q4 | $1.67M | Buy |
22,935
+1,209
| +6% | +$87.8K | 0.36% | 65 |
|
|
2021
Q3 | $1.52M | Buy |
21,726
+8,130
| +60% | +$568K | 0.39% | 60 |
|
|
2021
Q2 | $936K | Buy |
+13,596
| New | +$936K | 0.26% | 86 |
|
|
2020
Q4 | – | Sell |
-3,324
| Closed | -$210K | – | 230 |
|
|
2020
Q3 | $210K | Sell |
3,324
-161
| -5% | -$10.2K | 0.12% | 189 |
|
|
2020
Q2 | $268K | Buy |
3,485
+1,132
| +48% | +$87.1K | 0.14% | 140 |
|
|
2020
Q1 | $176K | Buy |
2,353
+182
| +8% | +$13.6K | 0.12% | 169 |
|
|
2019
Q4 | $141K | Buy |
+2,171
| New | +$141K | 0.09% | 217 |
|